https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
Adherence to core type 2 diabetes mellitus (T2DM) treatment behaviors is suboptimal, and nonadherence is generally not limited to one treatment behavior. The internet holds promise for programs that aim to improve adherence. We developed a computer-tailored eHealth program for patients with T2DM to improve their treatment adherence, that is, adherence to both a healthy lifestyle and medical behaviors. The objective of this study is to examine the effectiveness of the eHealth program in a randomized controlled trial.
Me gusta
Comentario
Compartir
